Why carry out this study?

Psychosocial comorbidities, including sleep difficulties, depression, and anxiety, are common among patients with moderate-to-severe atopic dermatitis (AD) in the USA.

This analysis was conducted to evaluate the relationship between these psychosocial comorbidities and health outcomes among adults with moderate-to-severe AD in the USA.

What was learned from this study?

These AD-related comorbidities—sleep difficulties, depression, and anxiety—are associated with a reduction in health status, health-related quality of life, and productivity in daily activities.

These comorbidities can also result in substantial economic burden based on direct healthcare costs and indirect costs from lost productivity.